Well, my understanding is that 50% to 60% of the actual cost of the medical isotopes is being subsidized by the Canadian taxpayer. What you are telling me, then, is that only 10% of those medical isotopes are actually being used by Canadians.
How will other countries' waste with respect to the production of isotopes--for example, that of the United States--impact on their ability to supply isotopes and the end-cost to the same end-users?